Oral Clindamycin Dosing
For adults, the standard oral clindamycin dose is 150-450 mg every 6-8 hours depending on infection severity; for children, use 8-20 mg/kg/day divided into 3-4 doses based on infection severity.
Adult Dosing
Based on FDA labeling 1:
- Serious infections: 150-300 mg every 6 hours
- More severe infections: 300-450 mg every 6 hours
For specific dermatologic conditions, 300 mg twice daily (BID) is effective for pharyngotonsillitis and skin infections 2. A single 600 mg dose is well-tolerated for prophylaxis 3.
Important caveat: When combined with rifampicin (for bone/joint infections), oral clindamycin is inadequate due to dramatically reduced bioavailability—IV administration of at least 3600-4800 mg/day is required 4.
Pediatric Dosing
The FDA label 1 provides weight-based dosing for children who can swallow capsules:
- Serious infections: 8-16 mg/kg/day divided into 3-4 equal doses
- More severe infections: 16-20 mg/kg/day divided into 3-4 equal doses
Dose based on total body weight regardless of obesity 1.
Pathogen-Specific Pediatric Dosing from Guidelines
The 2011 IDSA/PIDS pneumonia guidelines 5, 6, 5 provide more granular recommendations:
Oral therapy:
- MRSA (clindamycin-susceptible): 30-40 mg/kg/day in 3-4 divided doses
- Group A Streptococcus: 40 mg/kg/day in 3 doses
- Methicillin-susceptible S. aureus: 30-40 mg/kg/day in 3-4 divided doses
- Resistant S. pneumoniae (alternative): 30-40 mg/kg/day in 3 doses
Parenteral therapy (when oral inadequate): 40 mg/kg/day divided every 6-8 hours 5, 6
Real-World Pediatric Musculoskeletal Infection Data
A 2016 retrospective study 7 demonstrated that 30 mg/kg/day was as effective as 40 mg/kg/day for pediatric musculoskeletal infections in MRSA-prevalent communities, with no difference in readmission rates. The lower dose had fewer sequelae (3.2% vs 12%, though not statistically significant). This supports using 30 mg/kg/day for step-down oral therapy in appropriate cases.
Historical data from osteomyelitis treatment used 50 mg/kg/day IV followed by 30 mg/kg/day orally with excellent outcomes 8.
Key Clinical Considerations
Administration: Take with a full glass of water to avoid esophageal irritation 1. Food affects absorption but bioequivalence is maintained 9.
Duration:
- β-hemolytic streptococcal infections require ≥10 days 1
- Musculoskeletal infections typically require 4-6 weeks total (average 32.8 days outpatient) 7
Capsule limitations: Children unable to swallow capsules require clindamycin palmitate oral solution, as capsules don't provide exact mg/kg doses 1.
Monitoring: During prolonged therapy, perform periodic liver/kidney function tests and blood counts 1.
Major pitfall: Clindamycin-associated diarrhea and Clostridioides difficile colitis can occur up to 2 months after treatment cessation—more common in elderly patients (>60 years) 1. Discontinue immediately if significant diarrhea develops 1.